Concurrent chemoradiotherapy for head and neck cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference40 articles.
1. Head and Neck Contracts Program: Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program;Cancer,1987
2. Preoperative chemotherapy in advanced resectable head and neck cancer;Schuller;Laryngoscope,1988
3. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck;Laramore;Int J Radiat Oncol Biol Phys,1992
4. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers;Paccagnella;J Natl Cancer Inst,1994
5. Chemo-radiotherapy as compared to radiotherapy alone significantly increases disease-free and overall survival in head and neck cancer patients after surgery;Bernier;Int J Radiat Oncol Biol Phys,2001
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Delivery and Effectiveness of Carboplatin via Targeted Delivery Compared to Passive Accumulation of Intravenously Injected Particles Releasing Carboplatin upon Irradiation;Radiation Research;2020-01-07
2. The localization and risk factors of squamous cell carcinoma in the oral cavity: A retrospective study of 1501 cases;Journal of Cranio-Maxillofacial Surgery;2018-02
3. ENT COBRA (Consortium for Brachytherapy Data Analysis): interdisciplinary standardized data collection system for head and neck patients treated with interventional radiotherapy (brachytherapy);Journal of Contemporary Brachytherapy;2016
4. Targeted concurrent chemoradiotherapy, by using improved microcapsules that release carboplatin in response to radiation, improves detectability by computed tomography as well as antitumor activity while reducing adverse effect in vivo;Biomedicine & Pharmacotherapy;2015-03
5. Imaging of lung metastases using CT-detectable microcapsules and their radiotherapeutic treatment using targeted carboplatin nanoparticles;International Journal of PIXE;2015-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3